Non-linear modifications enhance prediction of pathological response to pre-operative PD-1 blockade in lung cancer: A longitudinal hybrid radiological model
Major pathologic remission (MPR, residual tumor <10%) is a promising clinical endpoint for prognosis analysis in patients with lung cancer receiving pre-operative PD-1 blockade therapy. Most of the current biomarkers for predicting MPR such as PD-L1 and tumor mutation burden (TMB) need to be obta...
Saved in:
Main Authors: | Weiqiu Jin (Author), Yu Tian (Author), Wendi Xuzhang (Author), Hongda Zhu (Author), Ningyuan Zou (Author), Leilei Shen (Author), Changzi Dong (Author), Qisheng Yang (Author), Long Jiang (Author), Jia Huang (Author), Zheng Yuan (Author), Xiaodan Ye (Author), Qingquan Luo (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improving the prediction of Spreading Through Air Spaces (STAS) in primary lung cancer with a dynamic dual-delta hybrid machine learning model: a multicenter cohort study
by: Weiqiu Jin, et al.
Published: (2023) -
Cancer Burden Variations and Convergences in Globalization: A Comparative Study on the Tracheal, Bronchus, and Lung (TBL) and Liver Cancer Burdens Among WHO Regions from 1990 to 2019
by: Mengwei Zhang, et al.
Published: (2023) -
Is There a Place for PD-1-PD-L Blockade in Acute Myeloid Leukemia?
by: Laura Jimbu, et al.
Published: (2021) -
Blockade of PD-L1/PD-1 signaling promotes osteo-/odontogenic differentiation through Ras activation
by: So Mi Jeon, et al.
Published: (2022) -
Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives
by: Jin-Yu Sun, et al.
Published: (2020)